PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24188560-0	2013	Improvement of superoxide dismutase and catalase in streptozotocin-nicotinamide-induced type 2-diabetes in mice by berberine and glibenclamide.	Streptozocin	52-66	catalase	Mus musculus	40-48	
32417177-8	2020	reversed STZ-induced alterations in the levels of reactive oxygen species, nitric oxide, and lipid peroxidation and the superoxide dismutase and catalase activities in the prefrontal cortices (PFC) and hippocampi (HC) of mice.	Streptozocin	9-12	catalase	Mus musculus	145-153	
32742373-10	2020	A significant decrease in the levels of superoxide dismutase and catalase, in addition to an increase in malondialdehyde, were observed in the livers of untreated STZ mice, all of which were significantly reversed by treatment with PILE 100 for 8 weeks.	Streptozocin	163-166	catalase	Mus musculus	65-73	
26113412-10	2015	However, reduced brain macrophages significantly inhibited the STZ-induced decreases in brain MDA, catalase and superoxidase anion-positive cells, and the STZ-induced decreases in brain NO.	Streptozocin	63-66	catalase	Mus musculus	99-107	
18089839-5	2008	It was also found that STZ treatment induced higher levels of reactive oxygen species, which was abolished with concomitant treatment with catalase.	Streptozocin	23-26	catalase	Mus musculus	139-147	
22475793-10	2012	Moreover, STZ (3 mg/kg) increased hippocampal S100B levels in both groups and SOD/CAT ratio in the sedentary animals.	Streptozocin	10-13	catalase	Mus musculus	82-85	
24846906-9	2013	Concurrent administration of STZ and vitamins caused a significant increase (compared to the diabetes group) in SOD, CAT, GPx, GSH content, and a decrease in IL-6 levels (p < 0.05).	Streptozocin	29-32	catalase	Mus musculus	117-120	
22315314-4	2012	Diabetes was induced by multiple injections of low-dose streptozotocin into catalase knock-out (CKO) and wild-type (WT) C57BL/6 mice.	Streptozocin	56-70	catalase	Mus musculus	76-84	
15855331-5	2005	Coexpression of MnSOD and catalase provided synergistic protection against peroxynitrite and STZ.	Streptozocin	93-96	catalase	Mus musculus	26-34	
17765928-3	2007	Adult wild-type (FVB) and transgenic mice with cardiac-specific overexpression of catalase were made diabetic by a single injection of streptozotocin (STZ, 220 mg/kg; i.p., maintained for two weeks).	Streptozocin	135-149	catalase	Mus musculus	82-90	
15855331-4	2005	MnSOD or catalase conferred protection against streptozotocin (STZ)-induced beta-cell injury.	Streptozocin	47-61	catalase	Mus musculus	9-17	
15855331-4	2005	MnSOD or catalase conferred protection against streptozotocin (STZ)-induced beta-cell injury.	Streptozocin	63-66	catalase	Mus musculus	9-17